MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BHVN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Biohaven (BHVN) Ownership - Who owns Biohaven?

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
c/o Biohaven Pharmaceuticals, Inc
Phone
+1 203 404-0410
Employees
274
Web
https://www.biohaven.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.92B
P/E Ratio
N/A
Total Cash
267.87M
Projected Growth
N/A
Total Debt
297.04M
Revenue
N/A
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
1.77
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
BHVN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for BHVN
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
c/o Biohaven Pharmaceuticals, Inc
Phone
+1 203 404-0410
Employees
274
Web
https://www.biohaven.com
Who owns Biohaven? BHVN symbol Ownership - Tickeron.com